Blood pressure variability: An additional target for antihypertensive treatment?

Hypertension

Volumn 58, Issue 2, 2011, Pages 133-135

  Schillaci, Giuseppe ^a   Pucci, Giacomo ^a   Parati, Gianfranco ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDAPAMIDE; LACIDIPINE; PLACEBO;

ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE FLUCTUATION; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; DIABETES MELLITUS; DIABETIC PATIENT; DRUG EFFECT; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; LONG TERM CARE; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; MULTICENTER STUDY (TOPIC); PATIENT COMPLIANCE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STIMULUS RESPONSE; SUSTAINED DRUG RELEASE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPERTENSION;

EID: 80051474380     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.175752     Document Type: Review

References (27)

1. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, Grassi G, Di Rienzo M, Pedotti A, Zanchetti A. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res. 1983;53:96-104. (Pubitemid 13031772)
2. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease: part 1-prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774. (Pubitemid 20106689)
3. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target organ damage. J Hypertens. 1987;5:93-98. (Pubitemid 17058039)
4. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-h blood pressure variability. J Hypertens. 1993;11:1133-1137. (Pubitemid 23307888)
5. Sander D, Kukla C, Klingelhofer J, Winbeck K, Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation. 2000;102: 1536-1541.
6. Kikuya M, Hozawa A, Ohkubo T, Tsuji I, Michimata, Matsubara M, Ota M, Nagai K, Araki T, Satoh H, Ito S, Hisamichi S, Imai Y. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama Study. Hypertension. 2000;38:23-29.
7. Mancia G, Parati G, Hennig M, Flatau B, Omboni S, Glavina F, Costa B, Scherz R, Bond G, Zanchetti A, for the ELSA Investigators. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens. 2001;19:1981-1989. (Pubitemid 33035803)
8. Pringle E, Phillips C, Thijs L, Davidson C, Staessen JA, de Leeuw PW, Jaaskivi M, Nachev C, Parati G, O'Brien ET, Tuomilehto J, Webster J, Bulpitt CJ, Fagard RH, for the Syst-Eur investigators. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens. 2003;21:2251-2257. (Pubitemid 38293563)
9. Schillaci G, Verdecchia P, Borgioni C, Ciucci A, Porcellati C. Lack of association between blood pressure variability and left ventricular mass in essential hypertension. Am J Hypertens. 1998;11:515-522. (Pubitemid 28270711)
10. Ozawa M, Tamura K, Iwatsubo K, Matsushita K, Sakai M, Tsurumi-Ikeya Y, Azuma K, Shigenaga A, Okano Y, Masuda S, Wakui H, Ishigami T, Umemura S. Ambulatory blood pressure variability is increased in diabetic hypertensives. Clin Exp Hypertens. 2008;30: 213-224. (Pubitemid 351556173)
11. Schillaci G, Parati G. Determinants of blood pressure variability in youth: at the roots of hypertension. J Hypertens. 2010;28:660-664.
12. Parati G, Omboni S, Rizzoni D, Agabiti-Rosei E, Mancia G. The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens. 1998;16:1685-1691. (Pubitemid 28515496)
13. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, Poulter NR, Sever PS, for the ASCOT-BPLA and MRC Trial Investigators. Effects of-blockers and calcium-channel blockers on withinindividual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9:469-480.
14. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive- drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010;375:906-915.
15. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895-905.
16. Mancia G, Parati G, Bilo G, Maronati A, Omboni S, Baurecht H, Hennige M, Zanchetti A. Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 2007;25:1087-1094. (Pubitemid 46573129)
17. Frattola A, Parati G, Castiglioni P, Paleari F, Ulian L, Rovaris G, Mauri G, Di Rienzo M, Mancia G. Lacidipine and blood pressure variability in diabetic hypertensive patients. Hypertension. 2000;36:622-628.
18. Zhang Y, Agnoletti D, Safar ME, Blacher J. Effect of antihypertensive agents on blood pressure variability: the Natrilix SR Versus Candesartan and Amlodipine in the Reduction of Systolic Blood Pressure in Hypertensive Patients (X-CELLENT) Study. Hypertension. 2011;58:155-160.
19. Bilo G, Giglio A, Styczkiewicz K, Caldara G, Maronati A, Kawecka-Jaszcz K, Mancia G, Parati G. A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J Hypertens. 2007;25:2058-2066. (Pubitemid 47476302)
20. Mena L, Pintos S, Queipo NV, Aizpúrua JA, Maestre G, Sulbarán T. A reliable index for the prognostic significance of blood pressure variability. J Hypertens. 2005;23:505-511. (Pubitemid 40684707)
21. Floras JS, Hassan MO, Vann Jones J, Osikowska BA, Sever PS, Sleight P. Factors influencing blood pressure and heart rate variability in hypertensive humans. Hypertension. 1988;11:273-281.
22. Mancia G, Di Rienzo M, Parati G, Grassi G. Sympathetic activity, blood pressure variability and end organ damage in hypertension. J Hum Hypertens. 1997;11(suppl 1):S3-S8. (Pubitemid 27424802)
23. Mancia G, Parati G, Pomidossi G, Casadei R, Di Rienzo M, Zanchetti A. Arterial baroreflexes and blood pressure and heart rate variabilities in humans. Hypertension. 1986;8:147-153. (Pubitemid 16105223)
24. Dabiré H, Lacolley P, Chaouche-Teyara K, Fournier B, Safar ME. Relationship between arterial distensibility and low-frequency power spectrum of blood pressure in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 2002;39:98-106. (Pubitemid 34028557)
25. Lacolley P, Bezie Y, Girerd X, Challande P, Benetos A, Boutouyrie P, Ghodsi N, Lucet B, Azoui R, Laurent S. Aortic distensibility and structural changes in sinoaortic-denervated rats. Hypertension. 1995;26: 337-340.
26. Di Rienzo M, Grassi G, Pedotti A, Mancia G. Continuous vs intermittent blood pressure measurements in estimating 24-hour average blood pressure. Hypertension. 1983;5:264-269. (Pubitemid 13164355)
27. Xie HH, Zhang XF, Chen YY, Shen FM, Su DF. Synergism of hydrochlorothiazide and nifedipine on blood pressure variability reduction and organ protection in spontaneously hypertensive rats. Hypertens Res. 2008;31:685-691.